NeuroBionics
Nicolette Driscoll is a highly accomplished bioengineer and technology innovator currently serving as Co-Founder and CTO at NeuroBionics since June 2023. With extensive experience in neural interfacing and bioelectronics, Nicolette held a Postdoctoral Research Fellow position at the Massachusetts Institute of Technology, focusing on multifunctional neural probes to investigate substance use disorders. Prior to this, Nicolette completed another Postdoctoral Research Fellow role at the University of Pennsylvania, leading the validation of high-density dry EEG electrodes. Educational achievements include a PhD in Bioengineering from the University of Pennsylvania and a BS in Biomedical/Medical Engineering from Brown University. Nicolette has also contributed significantly as a research assistant and graduate teaching assistant across various prestigious institutions, demonstrating a strong commitment to advancing neuroscience technology.
This person is not in any teams
This person is not in any offices
NeuroBionics
NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. Our core technology lies in flexible, multifunctional fibers the size of a human hair, which can record and stimulate neural activity, deliver drugs, and ablate tissue. Using an endovascular approach, we will navigate our microscopic-sized flexible fiber implant through the intricate network of blood vessels to deliver precise therapeutic intervention to neural tissue. By making neural interfacing a minimally-invasive procedure, we will revolutionize deep brain stimulation and broaden access to this lifechanging therapy. By doing so, we aim to improve the lives of millions grappling with conditions like Parkinson's disease, essential tremor, epilepsy, and depression.